Biofarm S.A. (BVB:BIO)

Biofarm Statistics

Total Valuation

Biofarm has a market cap or net worth of RON 648.37 million. The enterprise value is 525.54 million.

Market Cap	648.37M
Enterprise Value	525.54M

Important Dates

The last earnings date was Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	Aug 18, 2025

Share Statistics

Biofarm has 985.37 million shares outstanding. The number of shares has increased by 0.41% in one year.

Current Share Class	985.37M
Shares Outstanding	985.37M
Shares Change (YoY)	+0.41%
Shares Change (QoQ)	+40.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	88.33%
Float	477.14M

Valuation Ratios

The trailing PE ratio is 9.59.

PE Ratio	9.59
Forward PE	n/a
PS Ratio	2.26
PB Ratio	1.36
P/TBV Ratio	1.36
P/FCF Ratio	18.97
P/OCF Ratio	11.26
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.52, with an EV/FCF ratio of 15.38.

EV / Earnings	7.06
EV / Sales	1.83
EV / EBITDA	5.52
EV / EBIT	6.72
EV / FCF	15.38

Financial Position

The company has a current ratio of 4.34, with a Debt / Equity ratio of 0.00.

Current Ratio	4.34
Quick Ratio	3.60
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.03
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 16.30% and return on invested capital (ROIC) is 10.69%.

Return on Equity (ROE)	16.30%
Return on Assets (ROA)	9.32%
Return on Invested Capital (ROIC)	10.69%
Return on Capital Employed (ROCE)	16.30%
Revenue Per Employee	768,825
Profits Per Employee	199,456
Employee Count	373
Asset Turnover	0.55
Inventory Turnover	0.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.16% in the last 52 weeks. The beta is 0.28, so Biofarm's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	-19.16%
50-Day Moving Average	0.68
200-Day Moving Average	0.73
Relative Strength Index (RSI)	44.25
Average Volume (20 Days)	27,996

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biofarm had revenue of RON 286.77 million and earned 74.40 million in profits. Earnings per share was 0.07.

Revenue	286.77M
Gross Profit	239.62M
Operating Income	78.23M
Pretax Income	84.53M
Net Income	74.40M
EBITDA	95.26M
EBIT	78.23M
Earnings Per Share (EPS)	0.07

Balance Sheet

The company has 123.84 million in cash and 1.01 million in debt, giving a net cash position of 122.83 million or 0.12 per share.

Cash & Cash Equivalents	123.84M
Total Debt	1.01M
Net Cash	122.83M
Net Cash Per Share	0.12
Equity (Book Value)	478.26M
Book Value Per Share	0.49
Working Capital	252.84M

Cash Flow

In the last 12 months, operating cash flow was 57.59 million and capital expenditures -23.41 million, giving a free cash flow of 34.18 million.

Operating Cash Flow	57.59M
Capital Expenditures	-23.41M
Free Cash Flow	34.18M
FCF Per Share	0.03

Margins

Gross margin is 83.56%, with operating and profit margins of 27.28% and 25.94%.

Gross Margin	83.56%
Operating Margin	27.28%
Pretax Margin	29.48%
Profit Margin	25.94%
EBITDA Margin	33.22%
EBIT Margin	27.28%
FCF Margin	11.92%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 4.71%.

Dividend Per Share	0.03
Dividend Yield	4.71%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	3
Payout Ratio	39.24%
Buyback Yield	-0.41%
Shareholder Yield	4.31%
Earnings Yield	11.47%
FCF Yield	5.27%

Stock Splits

The last stock split was on April 30, 2008. It was a forward split with a ratio of 1.12001.

Last Split Date	Apr 30, 2008
Split Type	Forward
Split Ratio	1.12001

Scores

Biofarm has an Altman Z-Score of 8.53.

Altman Z-Score	8.53
Piotroski F-Score	n/a